Skip to main content

Table 1 Baseline characteristics of patients

From: Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study

Characteristics Calcitonin (n = 66) Celecoxib (n = 57) P value
Age, mean (years) ± SD 59.49 ± 9.32 61.54 ± 8.48 0.620
Sex, n (male) (%) 38 (57.58) 31 (54.39) 0.722
Smokers, n (%) 24 (36.36) 21 (36.84) 0.956
BMI, mean (kg/m2) ± SD 26.38 ± 4.12 25.31 ± 5.50 0.481
Pain VAS scores (0–10) 6.48 ± 1.08 6.52 ± 0.87 0.876
WOMAC scores    
 Total scores (0–96) 54.09 ± 10.24 54.60 ± 10.88 0.878
 Pain scores (0–20) 12.08 ± 4.09 12.15 ± 2.62 0.943
 Stiffness scores (0–8) 4.95 ± 0.97 4.90 ± 0.70 0.857
 Physical function scores (0–68) 37.07 ± 9.54 37.54 ± 11.31 0.883
Kellgren-Lawrence criteria, n (%)    
 Grade 1 11 (16.67%) 10 (17.54%) 0.986
 Grade 2 24 (36.37%) 20 (35.09%)  
 Grade 3 31 (49.96%) 27 (47.37%)  
BMLs scores 4.90 ± 1.35 4.95 ± 1.08 0.856
  1. BMI body mass index, VAS visual analog scale, WOMAC Western Ontario and McMaster Universities Osteoarthritis Index, BMLs bone marrow lesions